Cell and Gene Therapy Bioprocessing and Manufacture

The Modular Training for the Bioprocess Industries (MBI) programme pioneered by UCL Biochemical Engineering is a series of intensive short modules designed for professionals in the bioprocessing industry. The MBI Programme has a long history of equipping the bioprocessing industry's workforce with up-to-date skills and knowledge of process options in order to rapidly develop validatable, efficient and robust processes.

Cell and Gene Therapy is fast becoming an established field that aims to utilize the power of cell-based medicines to deliver new therapies for the 21st Century. However, translating the discovery science into manufacturable products has so far been challenging and so multi-disciplinary engineers who possess unique skills are urgently needed to address the manufacture of these complex medicinal products.

This course addresses the real-world challenges of translating discoveries to the clinic in a way that is commercially viable. A series of lectures and interactive case studies will enable you to:
 

  •  Understand the distinctions of manufacturing cells compared with biologics
  • Understand the challenges faced in advancing cell and gene therapies to clinic and the lessons learned from established companies
  • Understand the impact of design and engineering considerations on cell and gene therapy manufacture
  • Identify and define critical process parameters for different cell and gene therapy applications
  • Knowledge and application of analytical toolsets for quality measurement
  • Understand key implications to facilitate and expedite translation from laboratory to a manufacturing and clinical setting
The cost of the course includes tuition, course materials, lunches, refreshments and a networking dinner. Accommodation is not included.